vaccines

News

New York declares measles outbreak a "disaster emergency"

The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.

News

UK first country to launch CSL's trivalent flu shot Aujemflu

CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.

News

Bavarian Nordic has found its new CEO

Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.

R&D

Mosquitoes, malaria, and UK R&D viral disease vaccine invest...

The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.

News

GSK pushes 'next-generation' mRNA flu shot into phase 3

Buoyed by positive data in a phase 2 trial, GSK will start a phase 3 programme for an mRNA-based flu shot targeting both HA and NA flu antigens.

News

Pfizer, Valneva Lyme vaccine starts review in Europe

After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.

New York declares measles outbreak a "disaster emergency"

UK first country to launch CSL's trivalent flu shot Aujemflu

Bavarian Nordic has found its new CEO

Mosquitoes, malaria, and UK R&D viral disease vaccine invest...

GSK pushes 'next-generation' mRNA flu shot into phase 3

Pfizer, Valneva Lyme vaccine starts review in Europe

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

vaccines

Editor's Picks